Cargando…
Polyethylene Glycol Loxenatide Injection (GLP-1) Protects Vascular Endothelial Cell Function in Middle-Aged and Elderly Patients With Type 2 Diabetes by Regulating Gut Microbiota
Objective: To evaluate the protective effect of Polyethylene Glycol Loxenatide Injection (Glucagon-like peptide-1, GLP-1) on endothelial cells from middle-aged and elderly patients with newly diagnosed or poorly controlled type 2 diabetes mellitus (T2DM). GLP-1 weekly formulation was analyzed for ca...
Autores principales: | Chen, Fengwu, He, Lina, Li, Jilin, Yang, Shuhui, Zhang, Bangzhou, Zhu, Dan, Wu, Zezhen, Zhang, Shuo, Hou, Ducheng, Ouyang, Cong, Yi, Jianfeng, Xiao, Chuanxing, Hou, Kaijian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9240776/ https://www.ncbi.nlm.nih.gov/pubmed/35782875 http://dx.doi.org/10.3389/fmolb.2022.879294 |
Ejemplares similares
-
Efficacy of polyethylene glycol loxenatide versus insulin glargine on glycemic control in patients with type 2 diabetes: a randomized, open-label, parallel-group trial
por: Zhang, Shuo, et al.
Publicado: (2023) -
Vitamin D and Lipid Profiles in Postmenopausal Women: A Meta-Analysis and Systematic Review of Randomized Controlled Trials
por: Liu, Weiting, et al.
Publicado: (2021) -
Symptoms of depression, perceived social support, and medical coping modes among middle-aged and elderly patients with type 2 diabetes
por: Zhang, Chuanyan, et al.
Publicado: (2023) -
Fecal microbiota transplantation reverses insulin resistance in type 2 diabetes: A randomized, controlled, prospective study
por: Wu, Zezhen, et al.
Publicado: (2023) -
Fecal microbiota transplantation treatment of autoimmune-mediated type 1 diabetes mellitus
por: He, Lina, et al.
Publicado: (2022)